Literature DB >> 21997488

Outcomes of stable HIV-positive patients down-referred from a doctor-managed antiretroviral therapy clinic to a nurse-managed primary health clinic for monitoring and treatment.

Alana T Brennan1, Lawrence Long, Mhairi Maskew, Ian Sanne, Imogen Jaffray, Patrick MacPhail, Matthew P Fox.   

Abstract

OBJECTIVE: To compare clinical, immunologic and virologic outcomes among stable HIV-positive patients down-referred to a nurse-managed primary healthcare clinic (PHC) for treatment maintenance to those who remained at a doctor-managed treatment-initiation site.
DESIGN: We conducted a matched cohort analysis among stable HIV patients at the Themba Lethu Clinic in Johannesburg, South Africa. Eligible patients met the criteria for down-referral [undetectable viral load <10 months, antiretroviral therapy (ART) >11 months, CD4 cell count ≥200 cells/μl, stable weight and no opportunistic infections], regardless of whether they were down-referred to a PHC for treatment maintenance between February 2008 and January 2009. Patients were matched 1 : 3 (down-referred : treatment-initiation) using propensity scores.
METHODS: We calculated rates and hazard ratios (HRs) for the effect of down-referral on loss to follow-up (LTFU) and mortality and the relative risk of down-referral on viral rebound by 12 months of follow-up.
RESULTS: Six hundred and ninety-three down-referred patients were matched to 2079 treatment-initiation patients. Two (0.3%) down-referred and 32 (1.5%) treatment-initiation patients died, 10 (1.4%) down-referred and 87 (4.2%) treatment-initiation patients were lost, and 22 (3.3%) down-referred and 100 (5.6%) treatment-initiation patients experienced viral rebound by 12 months of follow-up. After adjustment, patients down-referred were less likely to die [hazard ratio (HR) 0.2, 95% confidence interval (CI) 0.04-0.8], become LTFU (HR 0.3, 95% CI 0.2-0.6) or experience viral rebound (relative risk 0.6, 95% CI 0.4-0.9) than treatment-initiation patients during follow-up.
CONCLUSION: The utilization of nurse-managed PHCs for treatment maintenance of stable patients could decrease the burden on specialized doctor-managed ART clinics. Patient outcomes for down-referred patients at PHCs appear equal, if not better, than those achieved at ART clinics among stable patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21997488      PMCID: PMC3669640          DOI: 10.1097/QAD.0b013e32834b6480

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  28 in total

Review 1.  Invited commentary: propensity scores.

Authors:  M M Joffe; P R Rosenbaum
Journal:  Am J Epidemiol       Date:  1999-08-15       Impact factor: 4.897

Review 2.  A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003.

Authors:  Peter C Austin
Journal:  Stat Med       Date:  2008-05-30       Impact factor: 2.373

3.  Rapid expansion of the health workforce in response to the HIV epidemic.

Authors:  Badara Samb; Francesca Celletti; Joan Holloway; Wim Van Damme; Kevin M De Cock; Mark Dybul
Journal:  N Engl J Med       Date:  2007-12-13       Impact factor: 91.245

4.  The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings.

Authors:  Charles F Gilks; Siobhan Crowley; René Ekpini; Sandy Gove; Jos Perriens; Yves Souteyrand; Don Sutherland; Marco Vitoria; Teguest Guerma; Kevin De Cock
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

5.  Quality of HIV care provided by nurse practitioners, physician assistants, and physicians.

Authors:  Ira B Wilson; Bruce E Landon; Lisa R Hirschhorn; Keith McInnes; Lin Ding; Peter V Marsden; Paul D Cleary
Journal:  Ann Intern Med       Date:  2005-11-15       Impact factor: 25.391

Review 6.  Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions.

Authors:  Elvin H Geng; Denis Nash; Andrew Kambugu; Yao Zhang; Paula Braitstein; Katerina A Christopoulos; Winnie Muyindike; Mwebesa Bosco Bwana; Constantin T Yiannoutsos; Maya L Petersen; Jeffrey N Martin
Journal:  Curr HIV/AIDS Rep       Date:  2010-11       Impact factor: 5.071

7.  Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa.

Authors:  Andrew Boulle; Gilles Van Cutsem; Katherine Hilderbrand; Carol Cragg; Musaed Abrahams; Shaheed Mathee; Nathan Ford; Louise Knight; Meg Osler; Jonny Myers; Eric Goemaere; David Coetzee; Gary Maartens
Journal:  AIDS       Date:  2010-02-20       Impact factor: 4.177

8.  Lessons learned during down referral of antiretroviral treatment in Tete, Mozambique.

Authors:  Tom Decroo; Isabella Panunzi; Carla das Dores; Fernando Maldonado; Marc Biot; Nathan Ford; Kathryn Chu
Journal:  J Int AIDS Soc       Date:  2009-05-06       Impact factor: 5.396

9.  Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial.

Authors:  Shabbar Jaffar; Barbara Amuron; Susan Foster; Josephine Birungi; Jonathan Levin; Geoffrey Namara; Christine Nabiryo; Nicaise Ndembi; Rosette Kyomuhangi; Alex Opio; Rebecca Bunnell; Jordan W Tappero; Jonathan Mermin; Alex Coutinho; Heiner Grosskurth
Journal:  Lancet       Date:  2009-11-24       Impact factor: 79.321

10.  Agreement between physicians and non-physician clinicians in starting antiretroviral therapy in rural Uganda.

Authors:  Ashwin Vasan; Nathan Kenya-Mugisha; Kwonjune J Seung; Marion Achieng; Patrick Banura; Frank Lule; Megan Beems; Jim Todd; Elizabeth Madraa
Journal:  Hum Resour Health       Date:  2009-08-20
View more
  43 in total

1.  HIV in Africa: Challenges and Directions for the Next Decade.

Authors:  Bruce L Gilliam; Devang Patel; Rohit Talwani; Zelalem Temesgen
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

Review 2.  A systematic review evaluating the impact of task shifting on access to antiretroviral therapy in sub-Saharan Africa.

Authors:  C A Emdin; P Millson
Journal:  Afr Health Sci       Date:  2012-09       Impact factor: 0.927

3.  Treatment outcomes after 7 years of public-sector HIV treatment.

Authors:  Matthew P Fox; Kate Shearer; Mhairi Maskew; William Macleod; Pappie Majuba; Patrick Macphail; Ian Sanne
Journal:  AIDS       Date:  2012-09-10       Impact factor: 4.177

4.  Superior outcomes and lower outpatient costs with scale-up of antiretroviral therapy at the GHESKIO clinic in Port-au-Prince, Haiti.

Authors:  Cynthia Riviere; Elizabeth Faust; Thane Miller; Eduard J Beck; Elaine Baruwa; Patrice Severe; Karine Severe; Claudia Thomas Riché; Rachelle Cassagnol; Sidney Atwood; Morgan Esperance; Lauren Webster; Pierre Cremieux; Jean W Pape; Serena P Koenig
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-01       Impact factor: 3.731

5.  Cohort profile: the Themba Lethu Clinical Cohort, Johannesburg, South Africa.

Authors:  Matthew P Fox; Mhairi Maskew; A Patrick MacPhail; Lawrence Long; Alana T Brennan; Daniel Westreich; William B MacLeod; Pappie Majuba; Ian M Sanne
Journal:  Int J Epidemiol       Date:  2012-03-20       Impact factor: 7.196

6.  Promoting Regulatory Reform: The African Health Profession Regulatory Collaborative (ARC) for Nursing and Midwifery Year 4 Evaluation.

Authors:  Maureen A Kelley; Sydney A Spangler; Laura I Tison; Carla M Johnson; Tegan L Callahan; Jill Iliffe; Kenneth W Hepburn; Jessica M Gross
Journal:  J Nurs Regul       Date:  2017-10

Review 7.  Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects.

Authors:  Larry W Chang; David Serwadda; Thomas C Quinn; Maria J Wawer; Ronald H Gray; Steven J Reynolds
Journal:  Lancet Infect Dis       Date:  2013-01       Impact factor: 25.071

8.  A Successful Model of Expedited Antiretroviral Therapy for Clinically Stable Patients Living With HIV in Haiti.

Authors:  Colette Guiteau Moise; Vanessa R Rivera; Kelly A Hennessey; Clovy Bellot; Chris Nicholas; Anna P Fang; Rose Irène Verdier; Patrice Severe; Alix Sainvil; Benedict Charles; Derothy Dorval; Juseline St Amour; Jean W Pape; Serena P Koenig
Journal:  J Acquir Immune Defic Syndr       Date:  2018-09-01       Impact factor: 3.731

Review 9.  Scale-up of HIV treatment through PEPFAR: a historic public health achievement.

Authors:  Wafaa M El-Sadr; Charles B Holmes; Peter Mugyenyi; Harsha Thirumurthy; Tedd Ellerbrock; Robert Ferris; Ian Sanne; Anita Asiimwe; Gottfried Hirnschall; Rejoice N Nkambule; Lara Stabinski; Megan Affrunti; Chloe Teasdale; Isaac Zulu; Alan Whiteside
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-15       Impact factor: 3.731

Review 10.  PEPFAR scale-up of pediatric HIV services: innovations, achievements, and challenges.

Authors:  Elaine J Abrams; R J Simonds; Surbhi Modi; Emilia Rivadeneira; Paula Vaz; Chipepo Kankasa; Denis Tindyebwa; B Ryan Phelps; Sara Bowsky; Chloe A Teasdale; Emilia Koumans; Andrea J Ruff
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-15       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.